Biogen (BIIB) Amortization - Intangibles (2009 - 2026)

Biogen (BIIB) has reported Amortization - Intangibles for 18 consecutive years, with $136.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Amortization - Intangibles rose 22.09% year-over-year to $136.5 million; the TTM figure through Mar 2026 stood at $539.7 million (up 12.39% YoY), while the FY2025 annual figure was $515.0 million, up 15.29% from the prior year.
• Amortization - Intangibles came in at $136.5 million for Q1 2026 at Biogen, roughly flat from $136.6 million in the prior quarter.
• The five-year high for Amortization - Intangibles was $175.0 million in Q4 2022, with the low at $50.2 million in Q1 2023.
• Average Amortization - Intangibles over 5 years is $100.3 million, with a median of $86.9 million recorded in 2024.
• The largest YoY upside for Amortization - Intangibles was 156.98% in 2022 against a maximum downside of 88.83% in 2022.
• Year by year, Amortization - Intangibles stood at $175.0 million in 2022, then tumbled by 56.23% to $76.6 million in 2023, then soared by 97.39% to $151.2 million in 2024, then fell by 9.66% to $136.6 million in 2025, then decreased by 0.07% to $136.5 million in 2026.
• According to Business Quant data, Amortization - Intangibles over the past three periods registered $136.5 million, $136.6 million, and $135.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.